-- 根據週一提交給香港交易所的公告，艾森康製藥（港交所代碼：6821，上海證券交易所代碼：002821）公佈第一季歸屬於股東的淨利潤為3.043億元人民幣，較上年同期的3.266億元下降6.8%。 這家醫藥外包服務公司在香港上市的股票在周二午盤交易中上漲近8%。 每股收益為0.84元人民幣，而上年同期為0.89元。 營收年增17%，從去年同期的15.4億元增至18億元。
Related Articles
US Markets
Novartis Reports First-quarter Sales Dip Amid Growing US Generic Competition
Novartis (NOVN.SW) on Tuesday reported a decline in first-quarter sales as an expected rise in generic penetration in the US outweighed the momentum of priority brands.Shares in the Swiss drugmaker was down 4% by midday trading.For the three months ended March 31, net sales were down 5% at constant currency to $13.11 billion. Volume added 13 percentage points to growth, but this was more than offset by a hit of 14 percentage points due to generic competition.Key therapies that continued to perform include leukemia treatment Scemblix, which surged 79% at constant currency to $433 million, and breast cancer drug Kisqali, which rose 55% to $1.52 billion. Conversely, revenue from heart failure drug Entresto dropped 46% to $1.31 billion.Against this backdrop, Novartis reiterated its 2026 financial targets, projecting low single-digit growth for net sales alongside a low single-digit decline in core operating income. Should late April exchange rates hold steady through year-end, currency tailwinds are projected to add 2 percentage points to net sales and 1 percentage point to core operating income, the company noted."With the momentum we are seeing across the business, we remain on track to deliver our [full-year] guidance and look forward to multiple readouts in the second half that could raise our mid- to long-term growth outlook," Novartis Chief Executive Officer Vas Narasimhan said.Novartis' net income reached $3.16 billion in the first quarter, down from $3.61 billion in the same period a year ago. EPS dropped to $1.65 from $1.83
$NOVN.SW
US Markets
Bank of Japan Holds Rates, Cuts Growth Outlook, Raises Inflation View
Citing heightened inflation risks but also a slowing economy, in a mixed decision the Bank of Japan kept its key interest rate unchanged, the central bank disclosed Tuesday.The Bank of Japan held its short-term policy rate at 0.75% by a 6-3 vote, leaving the rate unchanged since last December.Bank of Japan Governor Kazuo Ueda said policymakers need more time to assess how the Persian Gulf war and the closure of the Strait of Hormuz will affect prices and the economy.Demonstrating the impact of higher oil prices, the central bank forecast that the nation's consumer price index-core (CPI-core), that strips out fresh food prices, will rise 2.8% in fiscal 2026 (started April 1), up from the 1.9% estimate in January.In addition, the Bank of Japan lowered its forecast for gross domestic product (GDP) growth to 0.5% for the fiscal year, down from 1% in its the previous outlook.Until recent years, the Bank of Japan has struggled not with inflation but near-deflation, and also extended sluggish economic growth, resulting in what some critics termed "lost decades."In recent seasons, central bank officials have reiterated they want to keep demand for labor strong enough that real wages rise, thus allowing more consumption and overall economic expansion.Until today's forecast, the Bank of Japan also issued sanguine inflation forward estimate, that the CPI-core would recede to within the bank's 2% target in fiscal 2026.In fact, in March, Japan logged a modest 1.8% increase in the CPI-core on year, reported the Statistics Bureau.But going forward, with higher oil prices, and the weakest yen vs. the US dollar in 35 years, the Bank of Japan is now forecasting that inflation will rise above the central bank's target.Japan's central bank next meets on April 27-28."We continue to believe there's a chance that the BoJ may hike on 28 April," said ING Think, an rm of the Dutch investment house. "Board members' concerns about higher inflation expectations are likely to increase as real interest rates remain deeply negative."
$^N225
Asia
StanChart Buys Back Shares
Standard Chartered (HKG:2888) bought back 849,232 shares on Monday at an average price of 17.57 pounds sterling apiece, according to a Tuesday Hong Kong bourse filing.The British lender plans to cancel the shares, following which it will have about 2.22 billion shares in issue.
$HKG:2888